{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:53:06Z","timestamp":1788281586452,"version":"build-2803163510"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RO1DA034637"],"award-info":[{"award-number":["RO1DA034637"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA037117"],"award-info":[{"award-number":["R01DA037117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA011041"],"award-info":[{"award-number":["P30DA011041"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RC1DA028476"],"award-info":[{"award-number":["RC1DA028476"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005258","name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention","doi-asserted-by":"publisher","award":["U62\/CCU223595-03-1"],"award-info":[{"award-number":["U62\/CCU223595-03-1"]}],"id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206356","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:01:52Z","timestamp":1543518112000},"page":"e0206356","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment"],"prefix":"10.1371","volume":"13","author":[{"given":"Bilal","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-2869","authenticated-orcid":true,"given":"Ashly","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Neaigus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Des Jarlais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-0240","authenticated-orcid":true,"given":"Kirk","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"issue":"9791","key":"ref1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"The epidemiology of viral hepatitis among people who inject drugs: results of global systematic reviews","volume":"378","author":"P Nelson","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"KN Ly","year":"2012","journal-title":"Annals of internal medicine"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jvh.12338","article-title":"HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact","volume":"22","author":"NK Martin","year":"2015","journal-title":"Journal of viral hepatitis"},{"key":"ref4","article-title":"Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia","author":"J Iversen","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/hep.27736","article-title":"Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease","volume":"61","author":"AJ Leidner","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.28571","article-title":"Hepatitis C disease burden in the United States in the era of oral direct-acting antivirals","volume":"64","author":"J Chhatwal","year":"2016","journal-title":"Hepatology"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.drugpo.2015.05.006","article-title":"Hepatitis C transmission and treatment as prevention\u2014The role of the injecting network","volume":"26","author":"M Hellard","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/QCO.0000000000000216","article-title":"HCV treatment as prevention in people who inject drugs\u2014testing the evidence","volume":"28","author":"M Hickman","year":"2015","journal-title":"Current opinion in infectious diseases"},{"key":"ref9","article-title":"Effectiveness of needle\/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs","author":"L Platt","year":"2016","journal-title":"The Cochrane Library"},{"issue":"2","key":"ref10","article-title":"Modeling Combination HCV Prevention among HIV-infected Men Who Have Sex With Men and People Who Inject Drugs","volume":"19","author":"N Martin","year":"2017","journal-title":"AIDS reviews"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2009.12.028","article-title":"HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors","volume":"109","author":"DC Des Jarlais","year":"2010","journal-title":"Drug and alcohol dependence"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/08898480009525478","article-title":"A microsimulation study of the effect of concurrent partnerships on the spread of HIV in Uganda","volume":"8","author":"M Morris","year":"2000","journal-title":"Mathematical Population Studies"},{"issue":"11","key":"ref13","first-page":"1086","article-title":"Monte Carlo simulation of HIV infection in an intravenous drug user community","volume":"3","author":"D Peterson","year":"1990","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00128427","article-title":"The Spread of HIV into the General Population of the USA: A Simulation","volume":"15","author":"C Hewitt","year":"1996","journal-title":"Population Research and Policy Review"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2214-109X(13)70172-4","article-title":"Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models","volume":"2","author":"JW Eaton","year":"2014","journal-title":"The Lancet Global Health"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/QAD.0b013e3280187544","article-title":"The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda","volume":"21","author":"RH Gray","year":"2007","journal-title":"Aids"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6757928","article-title":"A stochastic differential equation model for the spread of HIV amongst people who inject drugs","volume":"2016","author":"Y Liang","year":"2016","journal-title":"Computational and mathematical methods in medicine"},{"issue":"2","key":"ref18","first-page":"247","article-title":"A method to estimate the size and characteristics of HIV-positive populations using an individual-based stochastic simulation model","volume":"27","author":"F Nakagawa","year":"2016","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/00207160701750583","article-title":"Stochastic simulation of HIV population dynamics through complex network modelling","volume":"85","author":"PM Sloot","year":"2008","journal-title":"International Journal of Computer Mathematics"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/QAI.0000000000000733","article-title":"A data-driven simulation of HIV spread among young men who have sex with men: the role of age and race mixing, and STIs","volume":"70","author":"EC Beck","year":"2015","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.matcom.2009.12.008","article-title":"Complex agent networks explaining the HIV epidemic among homosexual men in Amsterdam","volume":"80","author":"S Mei","year":"2010","journal-title":"Mathematics and Computers in Simulation"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13524-015-0383-4","article-title":"Sexual mixing in Shanghai: Are heterosexual contact patterns compatible with an HIV\/AIDS epidemic?","volume":"52","author":"MG Merli","year":"2015","journal-title":"Demography"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4054\/DemRes.2015.33.15","article-title":"Sexual networks, partnership mixing, and the female-to-male ratio of HIV infections in generalized epidemics: An agent-based simulation study","volume":"33","author":"G Reniers","year":"2015","journal-title":"Demographic Research"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s10461-016-1568-6","article-title":"The Interaction of Risk Network Structures and Virus Natural History in the Non-spreading of HIV Among People Who Inject Drugs in the Early Stages of the Epidemic","volume":"21","author":"K Dombrowski","year":"2017","journal-title":"AIDS and Behavior"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/720818","article-title":"Network firewall dynamics and the subsaturation stabilization of HIV","volume":"2013","author":"B Khan","year":"2013","journal-title":"Discrete dynamics in nature and society"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1377\/hlthaff.2013.0824","article-title":"Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs","volume":"33","author":"BD Marshall","year":"2014","journal-title":"Health Affairs"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1186\/s12889-017-4528-9","article-title":"The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study","volume":"17","author":"DJ Escudero","year":"2017","journal-title":"BMC public health"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1017\/S0950268815003180","article-title":"Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs","volume":"144","author":"J Monteiro","year":"2016","journal-title":"Epidemiology & Infection"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jtbi.2011.12.008","article-title":"Modelling hepatitis C transmission over a social network of injecting drug users","volume":"297","author":"D Rolls","year":"2012","journal-title":"Journal of theoretical biology"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"e78286","DOI":"10.1371\/journal.pone.0078286","article-title":"Hepatitis C transmission and treatment in contact networks of people who inject drugs","volume":"8","author":"DA Rolls","year":"2013","journal-title":"PloS one"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"e0137993","DOI":"10.1371\/journal.pone.0137993","article-title":"Agent-based model forecasts aging of the population of people who inject drugs in metropolitan Chicago and changing prevalence of hepatitis C infections","volume":"10","author":"A Gutfraind","year":"2015","journal-title":"PloS one"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1109\/JBHI.2015.2471804","article-title":"A parallel sliding region algorithm to make agent-based modeling possible for a large-scale simulation: modeling hepatitis C epidemics in Canada","volume":"20","author":"WW Wong","year":"2016","journal-title":"IEEE journal of biomedical and health informatics"},{"key":"ref33","article-title":"Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact","author":"L MacGregor","year":"2017","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12916-015-0440-2","article-title":"The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments","volume":"13","author":"N Scott","year":"2015","journal-title":"BMC medicine"},{"issue":"suppl_2","key":"ref35","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"NK Martin","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"104","key":"ref36","doi-asserted-by":"crossref","first-page":"20141197","DOI":"10.1098\/rsif.2014.1197","article-title":"Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data","volume":"12","author":"R Sacks-Davis","year":"2015","journal-title":"Journal of The Royal Society Interface"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Liu S, Cipriano LE, Goldhaber-Fiebert JD. Combining Statistical Analysis and Markov Models with Public Health Data to Infer Age-Specific Background Mortality Rates for Hepatitis C Infection in the US. In: International Conference on Smart Health. Springer; 2014. p. 148\u2013149.","DOI":"10.1007\/978-3-319-08416-9_15"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","DOI":"10.2196\/resprot.4518","article-title":"Hepatitis C virus disease progression in people who inject drugs: protocol for a systematic review and meta-analysis","volume":"4","author":"J Combellick","year":"2015","journal-title":"JMIR research protocols"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/infdis\/jit520","article-title":"\u201cTo share or not to share?\u201d Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants","volume":"208","author":"BD Smith","year":"2013","journal-title":"The Journal of infectious diseases"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12879-016-1807-5","article-title":"Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis","volume":"16","author":"DJ Smith","year":"2016","journal-title":"BMC infectious diseases"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","article-title":"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis","volume":"26","author":"DJ Smith","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0037549714526947","article-title":"A stochastic agent-based model of pathogen propagation in dynamic multi-relational social networks","volume":"90","author":"B Khan","year":"2014","journal-title":"Simulation"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1097\/QAI.0000000000001430","article-title":"Achieving Greater HIV Prevention Impact Through CDC\u2019s National HIV Behavioral Surveillance System","volume":"75","author":"C Wejnert","year":"2017","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref44","unstructured":"CDC. HIV infection, risk, prevention, and testing behaviors among persons who inject drugs\u2014National HIV Behavioral Surveillance: injection drug use, 20 US cities, 2012. HIV Surveillance Special Report 2015c. 2016;11."},{"key":"ref45","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1097\/QAI.0000000000001407","article-title":"Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005\u20132012","volume":"75","author":"A Neaigus","year":"2017","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.03.039","article-title":"Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006\u20132013","volume":"152","author":"AE Jordan","year":"2015","journal-title":"Drug and alcohol dependence"},{"issue":"3-4","key":"ref47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-8733(95)00264-O","article-title":"Street-level drug markets: Network structure and HIV risk","volume":"17","author":"R Curtis","year":"1995","journal-title":"Social networks"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAI.0b013e31815d2f59","article-title":"Risk of hepatitis-related mortality increased among hepatitis C virus\/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study","volume":"47","author":"C Smit","year":"2008","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref49","article-title":"RDS analysis tool 7.1 user manual","author":"M Spiller","year":"2012"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.drugalcdep.2009.07.005","article-title":"Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users","volume":"105","author":"RD Burt","year":"2009","journal-title":"Drug and alcohol dependence"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pmedr.2017.02.001","article-title":"Hepatitis C serosorting among people who inject drugs in rural Puerto Rico","volume":"6","author":"I Duncan","year":"2017","journal-title":"Preventive Medicine Reports"},{"issue":"14","key":"ref52","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3109\/10826084.2013.796987","article-title":"A reexamination of connectivity trends via exponential random graph modeling in two IDU risk networks","volume":"48","author":"K Dombrowski","year":"2013","journal-title":"Substance use & misuse"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"e100749","DOI":"10.1371\/journal.pone.0100749","article-title":"Per-event probability of hepatitis C infection during sharing of injecting equipment","volume":"9","author":"L Boelen","year":"2014","journal-title":"PloS one"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1002\/9780470515211","article-title":"Network modeling and simulation: a practical perspective","author":"M Guizani","year":"2010"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.21091","article-title":"Progression of liver fibrosis among injection drug users with chronic hepatitis C","volume":"43","author":"LE Wilson","year":"2006","journal-title":"Hepatology"},{"issue":"20","key":"ref56","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"E Lawitz","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"KM Turner","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ypmed.2009.04.014","article-title":"The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994\u20132004","volume":"49","author":"D Holtzman","year":"2009","journal-title":"Preventive medicine"},{"issue":"12","key":"ref59","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"JI Tsui","year":"2014","journal-title":"JAMA internal medicine"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.qai.0000186391.49205.3b","article-title":"Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility","volume":"41","author":"A Neaigus","year":"2006","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/00031305.1999.10474445","article-title":"One-factor-at-a-time versus designed experiments","volume":"53","author":"V Czitrom","year":"1999","journal-title":"The American Statistician"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group\u20136","volume":"32","author":"AH Briggs","year":"2012","journal-title":"Medical Decision Making"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients","volume":"30","author":"Y Benhamou","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2005.07.006","article-title":"Slower fibrosis progression in HIV\/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy","volume":"44","author":"N Br\u00e4u","year":"2006","journal-title":"Journal of hepatology"},{"issue":"5","key":"ref65","doi-asserted-by":"crossref","first-page":"S1092","DOI":"10.1016\/S0016-5085(17)33680-6","article-title":"Undetectable Serum HCV Antigens After 12 Weeks of HCV DAA Treatment Predicts Sustained Virologic Response","volume":"152","author":"KQ Hu","year":"2017","journal-title":"Gastroenterology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T22:13:14Z","timestamp":1720822394000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206356"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206356","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]}}}